Impact and Cost of a Pharmacist Pneumococcal Vaccination Program With PNEUMOVAX® 23 at an Urban Senior Center
Condition: Study is Open to Seniors Age 50 or Older
Intervention: Pharmacist Pneumococcal Vaccine Program (PPVP)
Intervention description: 1.5 hour educational intervention delivered onsite at collaborating senior center consisting of 3 components: presentation about pneumococcal disease and the vaccine given by a infectious disease-certified pharmacist; 2) skits given by volunteer actors at the senior center to illustrate real world scenarios related to pneumococcal disease and the vaccine; 3) action planning to consist of small group breakouts led by licensed pharmacists and 4) vaccination day which is an optional component following the education program, for participants eligible to receive the vaccine. Vaccination to be provided free of charge to eligible participants who opt to receive it.
Intervention MeSH terms: Heptavalent Pneumococcal Conjugate Vaccine
Phase: Phase 4
Study type: Interventional
Primary purpose: Health Services Research
Intervention model: Single Group Assignment
Masking: None (Open Label)
Enrollment: 203.0
Sex: All
Minimum age: 50 Years
Healthy volunteers: Accepts Healthy Volunteers
Keywords: pneumococcal vaccine; pharmacist vaccination; Pneumovax 23; pneumococcal vaccine polyvalent

Summary:

      The overall goals of this program are to measure the impact of a pharmacist pneumococcal
      vaccine education program (PPVP) using a senior center model of care and provide the
      pneumococcal vaccine to eligible participants.

      Hypotheses

        1. PPVP will result in improved knowledge and awareness in older minorities in the senior
           center setting (primary hypothesis);

        2. Participants who are vaccinated through the project will experienced increased trust in
           receiving vaccines from a pharmacist;

        3. Participants will be satisfied with and trust the PV information provided by pharmacists
           in the PPVP;

        4. PPVP is an efficient approach to educating patients in the senior center based on its
           costs;

        5. Participating pharmacists will be activated to implement PPVP learnings in their
           practice.
    

Eligibility criteria:

        Inclusion Criteria:

        A. Inclusions for PPVP:

          1. Age ≥ 50 years old

          2. Can attend a 1.5-hour session at CIP

          3. Cognitively intact based on responses to an Abbreviated Mental Test Score (AMTS) of ≥7
             (see Appendix for AMTS instrument)

          4. Can speak and read English at ≥4th grade level as evidenced by ability to read a brief
             passage

          5. Access to a telephone

        B. Inclusions to receive the optional pneumococcal vaccination:

        Patient meets ≥1 of the following criteria for receiving their first pneumococcal
        vaccination:

          1. All adults age 65 years and older who have not had the vaccine previously

          2. Age 50-64 years with any of the following conditions:

               1. Cigarette smokers age 19 years and older

               2. Chronic cardiovascular disease (e.g., congestive heart failure, cardiomyopathies;
                  excluding hypertension)

               3. Chronic pulmonary disease (including COPD and emphysema, and for adults ages 19
                  years and older, asthma)

               4. Diabetes mellitus

               5. Alcoholism

               6. Chronic liver disease, cirrhosis

               7. Candidate for or recipient of cochlear implant

               8. Functional or anatomic asplenia (e.g., sickle cell disease, splenectomy)

               9. Immunocompromising conditions or on immunosuppressive therapy

              10. Chronic renal failure or nephrotic syndrome

        OR

        Patient meets ≥1 of the following criteria for receiving a booster dose of the pneumococcal
        vaccination:

          1. Adults age 65 years and older who received their first dose for any indication when
             they were younger than age 65 years.

          2. Adults age 50-64 who have not received the vaccine for ≥5 years and have one of the
             following conditions:

               1. Functional or anatomic asplenia (including persons with sickle cell disease or
                  splenectomy patients);

               2. Chronic renal failure (including dialysis patients) or nephrotic syndrome;

               3. Immunocompromising conditions or on immunosuppressive therapy

        Exclusion Criteria:

        A. Exclusions to the PPVP program: none

        B. Exclusions to receiving the optional pneumococcal vaccine:

          1. Participant has a history of allergic reaction to pneumococcal vaccine

          2. Participant has a history of allergic reaction to any component of any vaccine

          3. Participant with moderate or severe illness (these individuals will be advised to
             speak to their doctor regarding the vaccine)